Table of Contents United States Synovial Sarcoma Treatment Market Report 2017 1 Synovial Sarcoma Treatment Overview 1.1 Product Overview and Scope of Synovial Sarcoma Treatment 1.2 Classification of Synovial Sarcoma Treatment by Product Category 1.2.1 United States Synovial Sarcoma Treatment Market Size (Sales Volume) Comparison by Type (2012-2022) 1.2.2 United States Synovial Sarcoma Treatment Market Size (Sales Volume) Market Share by Type (Product Category) in 2016 1.2.3 ACXT-3102 1.2.4 AL-3818 1.2.5 Axitinib 1.2.6 CMB-305 1.2.7 CUE-102 1.2.8 Others 1.3 United States Synovial Sarcoma Treatment Market by Application/End Users 1.3.1 United States Synovial Sarcoma Treatment Market Size (Consumption) and Market Share Comparison by Application (2012-2022) 1.3.2 Hospital 1.3.3 Clinic 1.3.4 Others 1.4 United States Synovial Sarcoma Treatment Market by Region 1.4.1 United States Synovial Sarcoma Treatment Market Size (Value) Comparison by Region (2012-2022) 1.4.2 The West Synovial Sarcoma Treatment Status and Prospect (2012-2022) 1.4.3 Southwest Synovial Sarcoma Treatment Status and Prospect (2012-2022) 1.4.4 The Middle Atlantic Synovial Sarcoma Treatment Status and Prospect (2012-2022) 1.4.5 New England Synovial Sarcoma Treatment Status and Prospect (2012-2022) 1.4.6 The South Synovial Sarcoma Treatment Status and Prospect (2012-2022) 1.4.7 The Midwest Synovial Sarcoma Treatment Status and Prospect (2012-2022) 1.5 United States Market Size (Value and Volume) of Synovial Sarcoma Treatment (2012-2022) 1.5.1 United States Synovial Sarcoma Treatment Sales and Growth Rate (2012-2022) 1.5.2 United States Synovial Sarcoma Treatment Revenue and Growth Rate (2012-2022) 2 United States Synovial Sarcoma Treatment Market Competition by Players/Suppliers 2.1 United States Synovial Sarcoma Treatment Sales and Market Share of Key Players/Suppliers (2012-2017) 2.2 United States Synovial Sarcoma Treatment Revenue and Share by Players/Suppliers (2012-2017) 2.3 United States Synovial Sarcoma Treatment Average Price by Players/Suppliers (2012-2017) 2.4 United States Synovial Sarcoma Treatment Market Competitive Situation and Trends 2.4.1 United States Synovial Sarcoma Treatment Market Concentration Rate 2.4.2 United States Synovial Sarcoma Treatment Market Share of Top 3 and Top 5 Players/Suppliers 2.4.3 Mergers & Acquisitions, Expansion in United States Market 2.5 United States Players/Suppliers Synovial Sarcoma Treatment Manufacturing Base Distribution, Sales Area, Product Type 3 United States Synovial Sarcoma Treatment Sales (Volume) and Revenue (Value) by Region (2012-2017) 3.1 United States Synovial Sarcoma Treatment Sales and Market Share by Region (2012-2017) 3.2 United States Synovial Sarcoma Treatment Revenue and Market Share by Region (2012-2017) 3.3 United States Synovial Sarcoma Treatment Price by Region (2012-2017) 4 United States Synovial Sarcoma Treatment Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017) 4.1 United States Synovial Sarcoma Treatment Sales and Market Share by Type (Product Category) (2012-2017) 4.2 United States Synovial Sarcoma Treatment Revenue and Market Share by Type (2012-2017) 4.3 United States Synovial Sarcoma Treatment Price by Type (2012-2017) 4.4 United States Synovial Sarcoma Treatment Sales Growth Rate by Type (2012-2017) 5 United States Synovial Sarcoma Treatment Sales (Volume) by Application (2012-2017) 5.1 United States Synovial Sarcoma Treatment Sales and Market Share by Application (2012-2017) 5.2 United States Synovial Sarcoma Treatment Sales Growth Rate by Application (2012-2017) 5.3 Market Drivers and Opportunities 6 United States Synovial Sarcoma Treatment Players/Suppliers Profiles and Sales Data 6.1 Adaptimmune Therapeutics Plc 6.1.1 Company Basic Information, Manufacturing Base and Competitors 6.1.2 Synovial Sarcoma Treatment Product Category, Application and Specification 6.1.2.1 Product A 6.1.2.2 Product B 6.1.3 Adaptimmune Therapeutics Plc Synovial Sarcoma Treatment Sales, Revenue, Price and Gross Margin (2012-2017) 6.1.4 Main Business/Business Overview 6.2 Advenchen Laboratories LLC 6.2.2 Synovial Sarcoma Treatment Product Category, Application and Specification 6.2.2.1 Product A 6.2.2.2 Product B 6.2.3 Advenchen Laboratories LLC Synovial Sarcoma Treatment Sales, Revenue, Price and Gross Margin (2012-2017) 6.2.4 Main Business/Business Overview 6.3 EpiZyme Inc 6.3.2 Synovial Sarcoma Treatment Product Category, Application and Specification 6.3.2.1 Product A 6.3.2.2 Product B 6.3.3 EpiZyme Inc Synovial Sarcoma Treatment Sales, Revenue, Price and Gross Margin (2012-2017) 6.3.4 Main Business/Business Overview 6.4 Immune Design Corp 6.4.2 Synovial Sarcoma Treatment Product Category, Application and Specification 6.4.2.1 Product A 6.4.2.2 Product B 6.4.3 Immune Design Corp Synovial Sarcoma Treatment Sales, Revenue, Price and Gross Margin (2012-2017) 6.4.4 Main Business/Business Overview 6.5 Immunocore Ltd 6.5.2 Synovial Sarcoma Treatment Product Category, Application and Specification 6.5.2.1 Product A 6.5.2.2 Product B 6.5.3 Immunocore Ltd Synovial Sarcoma Treatment Sales, Revenue, Price and Gross Margin (2012-2017) 6.5.4 Main Business/Business Overview 6.6 Johnson & Johnson 6.6.2 Synovial Sarcoma Treatment Product Category, Application and Specification 6.6.2.1 Product A 6.6.2.2 Product B 6.6.3 Johnson & Johnson Synovial Sarcoma Treatment Sales, Revenue, Price and Gross Margin (2012-2017) 6.6.4 Main Business/Business Overview 6.7 Karyopharm Therapeutics Inc 6.7.2 Synovial Sarcoma Treatment Product Category, Application and Specification 6.7.2.1 Product A 6.7.2.2 Product B 6.7.3 Karyopharm Therapeutics Inc Synovial Sarcoma Treatment Sales, Revenue, Price and Gross Margin (2012-2017) 6.7.4 Main Business/Business Overview 6.8 Merck & Co Inc 6.8.2 Synovial Sarcoma Treatment Product Category, Application and Specification 6.8.2.1 Product A 6.8.2.2 Product B 6.8.3 Merck & Co Inc Synovial Sarcoma Treatment Sales, Revenue, Price and Gross Margin (2012-2017) 6.8.4 Main Business/Business Overview 6.9 Millennium Pharmaceuticals Inc 6.9.2 Synovial Sarcoma Treatment Product Category, Application and Specification 6.9.2.1 Product A 6.9.2.2 Product B 6.9.3 Millennium Pharmaceuticals Inc Synovial Sarcoma Treatment Sales, Revenue, Price and Gross Margin (2012-2017) 6.9.4 Main Business/Business Overview 6.10 Novartis AG 6.10.2 Synovial Sarcoma Treatment Product Category, Application and Specification 6.10.2.1 Product A 6.10.2.2 Product B 6.10.3 Novartis AG Synovial Sarcoma Treatment Sales, Revenue, Price and Gross Margin (2012-2017) 6.10.4 Main Business/Business Overview 6.11 Pfizer Inc 6.12 Takara Bio Inc 7 Synovial Sarcoma Treatment Manufacturing Cost Analysis 7.1 Synovial Sarcoma Treatment Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Price Trend of Key Raw Materials 7.1.3 Key Suppliers of Raw Materials 7.1.4 Market Concentration Rate of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.2.1 Raw Materials 7.2.2 Labor Cost 7.2.3 Manufacturing Expenses 7.3 Manufacturing Process Analysis of Synovial Sarcoma Treatment 8 Industrial Chain, Sourcing Strategy and Downstream Buyers 8.1 Synovial Sarcoma Treatment Industrial Chain Analysis 8.2 Upstream Raw Materials Sourcing 8.3 Raw Materials Sources of Synovial Sarcoma Treatment Major Manufacturers in 2016 8.4 Downstream Buyers 9 Marketing Strategy Analysis, Distributors/Traders 9.1 Marketing Channel 9.1.1 Direct Marketing 9.1.2 Indirect Marketing 9.1.3 Marketing Channel Development Trend 9.2 Market Positioning 9.2.1 Pricing Strategy 9.2.2 Brand Strategy 9.2.3 Target Client 9.3 Distributors/Traders List 10 Market Effect Factors Analysis 10.1 Technology Progress/Risk 10.1.1 Substitutes Threat 10.1.2 Technology Progress in Related Industry 10.2 Consumer Needs/Customer Preference Change 10.3 Economic/Political Environmental Change 11 United States Synovial Sarcoma Treatment Market Size (Value and Volume) Forecast (2017-2022) 11.1 United States Synovial Sarcoma Treatment Sales Volume, Revenue Forecast (2017-2022) 11.2 United States Synovial Sarcoma Treatment Sales Volume Forecast by Type (2017-2022) 11.3 United States Synovial Sarcoma Treatment Sales Volume Forecast by Application (2017-2022) 11.4 United States Synovial Sarcoma Treatment Sales Volume Forecast by Region (2017-2022) 12 Research Findings and Conclusion 13 Appendix 13.1 Methodology/Research Approach 13.1.1 Research Programs/Design 13.1.2 Market Size Estimation 13.1.3 Market Breakdown and Data Triangulation 13.2 Data Source 13.2.1 Secondary Sources 13.2.2 Primary Sources 13.3 Disclaimer

List of Tables and Figures Figure Product Picture of Synovial Sarcoma Treatment Figure United States Synovial Sarcoma Treatment Market Size (K Pcs) by Type (2012-2022) Figure United States Synovial Sarcoma Treatment Sales Volume Market Share by Type (Product Category) in 2016 Figure ACXT-3102 Product Picture Figure AL-3818 Product Picture Figure Axitinib Product Picture Figure CMB-305 Product Picture Figure CUE-102 Product Picture Figure Others Product Picture Figure United States Synovial Sarcoma Treatment Market Size (K Pcs) by Application (2012-2022) Figure United States Sales Market Share of Synovial Sarcoma Treatment by Application in 2016 Figure Hospital Examples Table Key Downstream Customer in Hospital Figure Clinic Examples Table Key Downstream Customer in Clinic Figure Others Examples Table Key Downstream Customer in Others Figure United States Synovial Sarcoma Treatment Market Size (Million USD) by Region (2012-2022) Figure The West Synovial Sarcoma Treatment Revenue (Million USD) and Growth Rate (2012-2022) Figure Southwest Synovial Sarcoma Treatment Revenue (Million USD) and Growth Rate (2012-2022) Figure The Middle Atlantic Synovial Sarcoma Treatment Revenue (Million USD) and Growth Rate (2012-2022) Figure New England Synovial Sarcoma Treatment Revenue (Million USD) and Growth Rate (2012-2022) Figure The South of US Synovial Sarcoma Treatment Revenue (Million USD) and Growth Rate (2012-2022) Figure The Midwest Synovial Sarcoma Treatment Revenue (Million USD) and Growth Rate (2012-2022) Figure United States Synovial Sarcoma Treatment Sales (K Pcs) and Growth Rate (2012-2022) Figure United States Synovial Sarcoma Treatment Revenue (Million USD) and Growth Rate (2012-2022) Figure United States Synovial Sarcoma Treatment Market Major Players Product Sales Volume (K Pcs) (2012-2017) Table United States Synovial Sarcoma Treatment Sales (K Pcs) of Key Players/Suppliers (2012-2017) Table United States Synovial Sarcoma Treatment Sales Share by Players/Suppliers (2012-2017) Figure 2016 United States Synovial Sarcoma Treatment Sales Share by Players/Suppliers Figure 2017 United States Synovial Sarcoma Treatment Sales Share by Players/Suppliers Figure United States Synovial Sarcoma Treatment Market Major Players Product Revenue (Million USD) (2012-2017) Table United States Synovial Sarcoma Treatment Revenue (Million USD) by Players/Suppliers (2012-2017) Table United States Synovial Sarcoma Treatment Revenue Share by Players/Suppliers (2012-2017) Figure 2016 United States Synovial Sarcoma Treatment Revenue Share by Players/Suppliers Figure 2017 United States Synovial Sarcoma Treatment Revenue Share by Players/Suppliers Table United States Market Synovial Sarcoma Treatment Average Price (USD/Pcs) of Key Players/Suppliers (2012-2017) Figure United States Market Synovial Sarcoma Treatment Average Price (USD/Pcs) of Key Players/Suppliers in 2016 Figure United States Synovial Sarcoma Treatment Market Share of Top 3 Players/Suppliers Figure United States Synovial Sarcoma Treatment Market Share of Top 5 Players/Suppliers Table United States Players/Suppliers Synovial Sarcoma Treatment Manufacturing Base Distribution and Sales Area Table United States Players/Suppliers Synovial Sarcoma Treatment Product Category Table United States Synovial Sarcoma Treatment Sales (K Pcs) by Region (2012-2017) Table United States Synovial Sarcoma Treatment Sales Share by Region (2012-2017) Figure United States Synovial Sarcoma Treatment Sales Share by Region (2012-2017) Figure United States Synovial Sarcoma Treatment Sales Market Share by Region in 2016 Table United States Synovial Sarcoma Treatment Revenue (Million USD) and Market Share by Region (2012-2017) Table United States Synovial Sarcoma Treatment Revenue Share by Region (2012-2017) Figure United States Synovial Sarcoma Treatment Revenue Market Share by Region (2012-2017) Figure United States Synovial Sarcoma Treatment Revenue Market Share by Region in 2016 Table United States Synovial Sarcoma Treatment Price (USD/Pcs) by Region (2012-2017) Table United States Synovial Sarcoma Treatment Sales (K Pcs) by Type (2012-2017) Table United States Synovial Sarcoma Treatment Sales Share by Type (2012-2017) Figure United States Synovial Sarcoma Treatment Sales Share by Type (2012-2017) Figure United States Synovial Sarcoma Treatment Sales Market Share by Type in 2016 Table United States Synovial Sarcoma Treatment Revenue (Million USD) and Market Share by Type (2012-2017) Table United States Synovial Sarcoma Treatment Revenue Share by Type (2012-2017) Figure Revenue Market Share of Synovial Sarcoma Treatment by Type (2012-2017) Figure Revenue Market Share of Synovial Sarcoma Treatment by Type in 2016 Table United States Synovial Sarcoma Treatment Price (USD/Pcs) by Types (2012-2017) Figure United States Synovial Sarcoma Treatment Sales Growth Rate by Type (2012-2017) Table United States Synovial Sarcoma Treatment Sales (K Pcs) by Application (2012-2017) Table United States Synovial Sarcoma Treatment Sales Market Share by Application (2012-2017) Figure United States Synovial Sarcoma Treatment Sales Market Share by Application (2012-2017) Figure United States Synovial Sarcoma Treatment Sales Market Share by Application in 2016 Table United States Synovial Sarcoma Treatment Sales Growth Rate by Application (2012-2017) Figure United States Synovial Sarcoma Treatment Sales Growth Rate by Application (2012-2017) Table Adaptimmune Therapeutics Plc Basic Information List Table Adaptimmune Therapeutics Plc Synovial Sarcoma Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017) Figure Adaptimmune Therapeutics Plc Synovial Sarcoma Treatment Sales Growth Rate (2012-2017) Figure Adaptimmune Therapeutics Plc Synovial Sarcoma Treatment Sales Market Share in United States (2012-2017) Figure Adaptimmune Therapeutics Plc Synovial Sarcoma Treatment Revenue Market Share in United States (2012-2017) Table Advenchen Laboratories LLC Basic Information List Table Advenchen Laboratories LLC Synovial Sarcoma Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017) Figure Advenchen Laboratories LLC Synovial Sarcoma Treatment Sales Growth Rate (2012-2017) Figure Advenchen Laboratories LLC Synovial Sarcoma Treatment Sales Market Share in United States (2012-2017) Figure Advenchen Laboratories LLC Synovial Sarcoma Treatment Revenue Market Share in United States (2012-2017) Table EpiZyme Inc Basic Information List Table EpiZyme Inc Synovial Sarcoma Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017) Figure EpiZyme Inc Synovial Sarcoma Treatment Sales Growth Rate (2012-2017) Figure EpiZyme Inc Synovial Sarcoma Treatment Sales Market Share in United States (2012-2017) Figure EpiZyme Inc Synovial Sarcoma Treatment Revenue Market Share in United States (2012-2017) Table Immune Design Corp Basic Information List Table Immune Design Corp Synovial Sarcoma Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017) Figure Immune Design Corp Synovial Sarcoma Treatment Sales Growth Rate (2012-2017) Figure Immune Design Corp Synovial Sarcoma Treatment Sales Market Share in United States (2012-2017) Figure Immune Design Corp Synovial Sarcoma Treatment Revenue Market Share in United States (2012-2017) Table Immunocore Ltd Basic Information List Table Immunocore Ltd Synovial Sarcoma Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017) Figure Immunocore Ltd Synovial Sarcoma Treatment Sales Growth Rate (2012-2017) Figure Immunocore Ltd Synovial Sarcoma Treatment Sales Market Share in United States (2012-2017) Figure Immunocore Ltd Synovial Sarcoma Treatment Revenue Market Share in United States (2012-2017) Table Johnson & Johnson Basic Information List Table Johnson & Johnson Synovial Sarcoma Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017) Figure Johnson & Johnson Synovial Sarcoma Treatment Sales Growth Rate (2012-2017) Figure Johnson & Johnson Synovial Sarcoma Treatment Sales Market Share in United States (2012-2017) Figure Johnson & Johnson Synovial Sarcoma Treatment Revenue Market Share in United States (2012-2017) Table Karyopharm Therapeutics Inc Basic Information List Table Karyopharm Therapeutics Inc Synovial Sarcoma Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017) Figure Karyopharm Therapeutics Inc Synovial Sarcoma Treatment Sales Growth Rate (2012-2017) Figure Karyopharm Therapeutics Inc Synovial Sarcoma Treatment Sales Market Share in United States (2012-2017) Figure Karyopharm Therapeutics Inc Synovial Sarcoma Treatment Revenue Market Share in United States (2012-2017) Table Merck & Co Inc Basic Information List Table Merck & Co Inc Synovial Sarcoma Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017) Figure Merck & Co Inc Synovial Sarcoma Treatment Sales Growth Rate (2012-2017) Figure Merck & Co Inc Synovial Sarcoma Treatment Sales Market Share in United States (2012-2017) Figure Merck & Co Inc Synovial Sarcoma Treatment Revenue Market Share in United States (2012-2017) Table Millennium Pharmaceuticals Inc Basic Information List Table Millennium Pharmaceuticals Inc Synovial Sarcoma Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017) Figure Millennium Pharmaceuticals Inc Synovial Sarcoma Treatment Sales Growth Rate (2012-2017) Figure Millennium Pharmaceuticals Inc Synovial Sarcoma Treatment Sales Market Share in United States (2012-2017) Figure Millennium Pharmaceuticals Inc Synovial Sarcoma Treatment Revenue Market Share in United States (2012-2017) Table Novartis AG Basic Information List Table Novartis AG Synovial Sarcoma Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017) Figure Novartis AG Synovial Sarcoma Treatment Sales Growth Rate (2012-2017) Figure Novartis AG Synovial Sarcoma Treatment Sales Market Share in United States (2012-2017) Figure Novartis AG Synovial Sarcoma Treatment Revenue Market Share in United States (2012-2017) Table Pfizer Inc Basic Information List Table Takara Bio Inc Basic Information List Table Production Base and Market Concentration Rate of Raw Material Figure Price Trend of Key Raw Materials Table Key Suppliers of Raw Materials Figure Manufacturing Cost Structure of Synovial Sarcoma Treatment Figure Manufacturing Process Analysis of Synovial Sarcoma Treatment Figure Synovial Sarcoma Treatment Industrial Chain Analysis Table Raw Materials Sources of Synovial Sarcoma Treatment Major Players/Suppliers in 2016 Table Major Buyers of Synovial Sarcoma Treatment Table Distributors/Traders List Figure United States Synovial Sarcoma Treatment Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022) Figure United States Synovial Sarcoma Treatment Revenue (Million USD) and Growth Rate Forecast (2017-2022) Figure United States Synovial Sarcoma Treatment Price (USD/Pcs) Trend Forecast (2017-2022) Table United States Synovial Sarcoma Treatment Sales Volume (K Pcs) Forecast by Type (2017-2022) Figure United States Synovial Sarcoma Treatment Sales Volume (K Pcs) Forecast by Type (2017-2022) Figure United States Synovial Sarcoma Treatment Sales Volume (K Pcs) Forecast by Type in 2022 Table United States Synovial Sarcoma Treatment Sales Volume (K Pcs) Forecast by Application (2017-2022) Figure United States Synovial Sarcoma Treatment Sales Volume (K Pcs) Forecast by Application (2017-2022) Figure United States Synovial Sarcoma Treatment Sales Volume (K Pcs) Forecast by Application in 2022 Table United States Synovial Sarcoma Treatment Sales Volume (K Pcs) Forecast by Region (2017-2022) Table United States Synovial Sarcoma Treatment Sales Volume Share Forecast by Region (2017-2022) Figure United States Synovial Sarcoma Treatment Sales Volume Share Forecast by Region (2017-2022) Figure United States Synovial Sarcoma Treatment Sales Volume Share Forecast by Region in 2022 Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources